An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial

By The REVIVE Study Group   Massicotte P.   Julian J.A.   Gent M.   Shields K.   Marzinotto V.   Szechtman B.   Andrew M.  

Thrombosis Research, Vol. 109, Iss. 2, 2003-01 ,pp. : 85-92

Elsevier

Access to resources Recommend Favorite

Low-molecular-weight heparin in the treatment of recurrent IVF-ET failure and thrombophilia: A prospective randomized placebo-controlled trial

By Qublan H.   Amarin Z.   Dabbas M.   Farraj A. -E.   Beni-Merei Z.   Al-Akash H.   Bdoor A. -N.   Nawasreh M.   Malkawi S.   Diab F.   Al-Ahmad N.   Balawneh M.   Abu-Salim A.  

Human Fertility, Vol. 11, Iss. 4, 2008-12 ,pp. : 246-253

Informa Healthcare

Access to resources Recommend Favorite

Luteal phase empirical low molecular weight heparin administration in patients with failed ICSI embryo transfer cycles: a randomized open-labeled pilot trial

By Urman B.   Ata B.   Yakin K.   Alatas C.   Aksoy S.   Mercan R.   Balaban B.  

Human Reproduction, Vol. 24, Iss. 7, 2009-07 ,pp. : 1640-1647

Oxford University Press

Access to resources Recommend Favorite

Impact of highly purified urinary FSH and recombinant FSH on haemostasis: an open‐label, randomized, controlled trial

By Ricci G.   Cerneca F.   Simeone R.   Pozzobon C.   Guarnieri S.   Sartore A.   Pregazzi R.   Guaschino S.  

Human Reproduction, Vol. 19, Iss. 4, 2004-04 ,pp. : 838-848

Oxford University Press

Access to resources Recommend Favorite

Prevention of Venous Thromboembolism - Prophylaxis with a low molecular weight heparin (Fragmin)

By Agnelli G.   Sonaglia F.  

Thrombosis Research, Vol. 97, Iss. 1, 2000-01 ,pp. : 49-62

Elsevier

Access to resources Recommend Favorite